(Q35563464)

8 August 2017

1 reference

title

The use of long-acting opioids in chronic pain management (English)

1 reference

8 August 2017

0 references

0 references

April Hazard Vallerand

series ordinal

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567201

22 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0029646502000944?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0029-6465(02)00094-4

https://api.elsevier.com/content/article/PII:S0029646502000944?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0029-6465(02)00094-4

The Nursing clinics of North America

22 March 2024

published in

1 reference

8 August 2017

38

1 reference

8 August 2017

3

1 reference

8 August 2017

435-445

1 reference

Pain evaluation and management in the nursing home

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Pharmacologic treatment of cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Controlled-release morphine tablets in patients with chronic cancer pain: a narrative review of controlled clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Long-term oral opioid therapy in patients with chronic nonmalignant pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Opioid therapy for chronic noncancer back pain. A randomized prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Opioids in non-cancer pain: a life-time sentence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Opioid therapy for chronic nonmalignant pain: a review of the critical issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Treatment of low back pain--significance, principles and danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Opioid tolerance: the clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0029-6465%2802%2900094-4

The management of persistent pain in older persons

7 January 2021

series ordinal

3

1 reference

https://api.crossref.org/works/10.1016/S0029-6465(02)00094-4

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference